Palma J et al. – HI–hematopoietic stem cell transplantation (HSCT) is feasible in setting, offers a rational treatment option, and expands the donor pool significantly for children with high–risk leukemia in a developing country. This information is especially relevant to other ethnically diverse populations that are poorly represented in international donor registries. [more...]